Drug Type Small molecule drug |
Synonyms HS-159 |
Target |
Mechanism PI3Kα inhibitors(Phosphatidylinositol 3 kinase alpha inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H17N5O2S |
InChIKeyFDKPMFANXHUMHE-UHFFFAOYSA-N |
CAS Registry1276110-17-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Hepatocellular Carcinoma | Preclinical | KR | 22 Apr 2013 |